Covid-19: JCVI opts not to recommend universal vaccination of 12-15 year olds

BMJ ◽  
2021 ◽  
pp. n2180
Author(s):  
Gareth Iacobucci
Keyword(s):  
Universal Vaccination

scholarly journals Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost

Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 144
Author(s):  
Florian Zeevat ◽  
Evgeni Dvortsin ◽  
Abrham Wondimu ◽  
Jan C. Wilschut ◽  
Cornelis Boersma ◽  
...  
Keyword(s):  
High Risk ◽  
The Netherlands ◽  
Herd Immunity ◽  
Vaccination Strategy ◽  
Quality Adjusted Life Year ◽  
High Risk Group ◽  
Universal Vaccination ◽  
Birth Cohorts ◽  
Rotavirus Vaccination ◽  
Immunization Programme

In this study, we estimated the benefits of rotavirus vaccination for infants had the rotavirus vaccine been introduced in the Netherlands as of its market authorization in 2006. An age-structured, deterministic cohort model was developed to simulate different birth cohorts over a period of 15 years from 2006 until 2021, comparing both universal and targeted high-risk group vaccination to no vaccination. Different scenarios for the duration of protection (5 or 7 years) and herd immunity (only for universal vaccination) were analyzed. All birth cohorts together included 2.6 million infants, of which 7.9% were high-risk individuals, and an additional 13.2 million children between 1–15 years born prior to the first cohort in 2006. The costs and health outcomes associated with rotavirus vaccination were calculated per model scenario and discounted at 4% and 1.5%, respectively. Our analysis reveals that, had rotavirus vaccination been implemented in 2006, it would have prevented 356,800 (51% decrease) and 32,200 (5% decrease) cases of rotavirus gastroenteritis after universal and targeted vaccination, respectively. Over the last 15 years, this would have led to significant avoided costs and quality-adjusted life year losses for either vaccination strategy with the most favorable outcomes for universal vaccination. Clearly, an opportunity has been lost.

scholarly journals Prevention of Hepatocellular Carcinoma by Universal Vaccination against Hepatitis B Virus: The Effect and Problems

2005 ◽  
Vol 11 (21) ◽  
pp. 7953-7957 ◽  
Author(s):  
Mei-Hwei Chang ◽  
Tony Hsiu-Hsi Chen ◽  
Hsu-Mei Hsu ◽  
Tzee-Chung Wu ◽  
Man-Shan Kong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Universal Vaccination ◽  
B Virus

Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes

Vaccine ◽  
2000 ◽  
Vol 19 (2-3) ◽  
pp. 183-188 ◽  
Author(s):  
Lluı́s Salleras ◽  
Àngela Domı́nguez ◽  
Josep Vidal ◽  
Pere Plans ◽  
Montserrat Salleras ◽  
...  
Keyword(s):  
Virus Infection ◽  
Varicella Zoster Virus ◽  
Universal Vaccination ◽  
Varicella Zoster Virus Infection ◽  
Varicella Zoster

scholarly journals Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over five years

2009 ◽  
Vol 14 (35) ◽  
Author(s):  
G Giammanco ◽  
S Ciriminna ◽  
I Barberi ◽  
L Titone ◽  
M Lo Giudice ◽  
...  
Keyword(s):  
Vaccination Programme ◽  
Vaccine Coverage ◽  
Varicella Vaccine ◽  
Age Groups ◽  
Vaccination Strategy ◽  
Paediatric Population ◽  
Incidence Rates ◽  
Universal Vaccination ◽  
Varicella Vaccination ◽  
Local Health

Following the licensure of the Oka/Merck varicella vaccine in Italy in January 2003, the Sicilian health authorities launched a universal vaccination programme in all nine Local Health Units. A two-cohort vaccination strategy was adopted to minimise the shift of the mean age of varicella occurrence to older age groups, with the goal of vaccinating with one dose at least 80% of children in their second year of life and 50% of susceptible adolescents in their 12th year of life. Two studies were implemented in parallel to closely monitor vaccination coverage as well as varicella incidence. Overall, the programme achieved its target, with 87.5% vaccine coverage for the birth cohort 2005 and 90.2% for adolescents born in 1995 and 1996. Varicella surveillance data obtained from a total of 28,188 children (0-14 years-old) monitored by family paediatricians showed a decline in incidence rates from 95.7 (95% confidence interval (CI): 72.2-126.8) for 1,000 person-years (PY) in 2004 to 9.0 (95% CI: 6.4-12.6) for 1,000 PY in 2007. In Europe, the only similar experience is the routine childhood varicella vaccination programme in Germany that started in 2004 with a single dose at the age of 11-14 months. The two-cohort universal vaccination programme implemented in Sicily, as well as the network for the surveillance study, can offer a model to other European countries that are considering introducing universal childhood varicella vaccination.

scholarly journals Hepatitis A in the European Union: responding to challenges related to new epidemiological patterns

2009 ◽  
Vol 14 (3) ◽  
Author(s):  
L Payne ◽  
D Coulombier
Keyword(s):  
European Union ◽  
Czech Republic ◽  
General Population ◽  
Hepatitis A ◽  
Universal Vaccination ◽  
The European Union ◽  
The Impact

In the European Union (EU), the overall incidence of hepatitis A has decreased over the last 10 years from 15.1 per 100,000 population in 1996 to 3.9 per 100,000 in 2006. However, reduction in circulation of HAV leads to decreased acquisition of immunity and, in the absence of universal vaccination, an accumulation of susceptible individuals. The impact of increasing susceptibility of the general population on the risk for outbreaks is clearly illustrated in independent outbreaks in Czech Republic, Latvia and Slovakia in 2008, described in three of the articles published in this week’s issue of Eurosurveillance.

scholarly journals Advice on universal vaccination of infants against both group C meningococci and pneumococci in the Netherlands

2002 ◽  
Vol 6 (5) ◽  
Author(s):  
H Houweling
Keyword(s):  
The Netherlands ◽  
Vaccination Programme ◽  
Universal Vaccination ◽  
Health Council ◽  
National Vaccination Programme

The Gezondheidsraad (Health Council) in the Netherlands was asked to advise the minister of health on the revision and possible expansion of the national vaccination programme, and consequently published a recommendation on universal vaccination against infections with group C meningococci and pneumococci recently.

Sign in / Sign up

Export Citation Format

Share Document